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Abstract
Infection with the hepatitis E virus (HEV) is one of the main causes of acute hepatitis worldwide. Given that, the
histopathology of hepatitis E is relatively poorly characterized, and it is unclear what exactly determines its remarkable
variability. The aim of our study was a systematic analysis of hepatitis E histology, especially with regard to the clinical
setting. Fifty-two liver samples (48 biopsies, 1 liver explant, 3 autopsy livers) from 41 patients with molecularly proven
hepatitis E (28 HEV genotype (gt) 3, three gt 1, one gt 4 and 9 undetermined gt) were systematically evaluated for 33
histopathologic features. Following one approach, the biopsies were assigned to one of five generic histologic patterns. In
another approach, they were subjected to hierarchical clustering. We found that 23/41 (56%) patients were
immunocompromised, whereas 18 (44%) had no known immunosuppression. Five patients (12%) had pre-existing liver
disease (LD). The histopathologic spectrum ranged from almost normal to acute, chronic, and steato-hepatitis to subtotal
necrosis, and was thus distributed across all five generic patterns. Hierarchical clustering, however, identified three
histopathologic clusters (C1–C3), which segregated along the immune status and pre-existing LD: C1 comprised mostly
patients with pre-existing LD; histology mainly reflected the respective LD without pointing to the additional hepatitis E. C2
comprised mostly immunocompetent patients; histology mainly displayed florid hepatitis. C3 comprised mostly
immunocompromised patients; histology mainly displayed smoldering hepatitis. Accordingly, C1–C3 differed markedly
with respect to their clinical and histopathologic differential diagnoses. Hierarchical clustering suggests three groups with
distinct histopathologies, indicating biologically different manifestations of hepatitis E. The association of histopathologic
changes with the patient’s immune status and pre-existing LD plausibly explains the diversity of hepatitis E histopathology,
and suggests that these factors are the crucial underlying determinants. We expect our results to improve patient management
by guiding the clinico-pathologic diagnosis of hepatitis E.
Introduction
Hepatitis E is caused by a water- or food-borne, enterically
transmitted infection with the hepatitis E virus (HEV),
a non-enveloped, positive-strand RNA virus [1, 2]. HEV
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infection is one of the most common causes of acute
hepatitis worldwide and thus represents a major global
health problem [3, 4]. The disease shows clear differences
between resource-rich and resource-limited countries in
terms of viral genotypes (gt), mode of transmission and
course of disease. Resource-limited countries are domi-
nated by gt 1 and gt 2, which occur endemically as well as
epidemically, are transmitted from humans to humans
predominantly by contaminated drinking water and occa-
sionally cause large epidemic outbreaks. By contrast,
resource-rich countries are dominated by zoonotic trans-
mission of HEV gt 3, which occurs worldwide, as well as
gt 4, which is mainly found in China and Southeast Asia.
Transmission of gt 3 and gt 4 often occurs through con-
taminated meat products [5].
The clinical course of hepatitis E is highly variable.
HEV gt 3 infection is usually asymptomatic or subclinical
but can also present as acute, self-limiting hepatitis,
or even as acute-on-chronic liver failure in patients with
pre-existing liver disease [3, 6]. Poor outcomes have also
been described in pregnant women infected with HEV gt 1
[3, 6]. Originally regarded as an exclusively acute infec-
tion, the experience of the last decade has shown that
hepatitis E of gt 3 can also develop a chronic course under
immunosuppression [7].
Shortly after a peculiar form of epidemic hepatitis, later
on designated as hepatitis E, had been identified as a distinct
disease in India in the mid-fifties [8], the histologic changes
observed in >70 cases of this outbreak were described [9].
For a long time, these reports, limited to the epidemic form
of hepatitis E and enriched for severe courses, were the only
ones available. Several decades later, the first histologic
descriptions of autochthonous hepatitis E were published in
smaller series [10–13], including HEV infection taking
a chronic course [7, 14–16]. Although a comprehensive,
comparative analysis of histology, especially with regard to
characteristics of the host, is still lacking, from the body of
literature on hepatitis E histology it is obvious that findings
are highly variable and overlapping with other causes of
hepatitis, thus, making a timely and accurate histopatholo-
gic diagnosis of HEV infection challenging [10, 14, 17–19].
Since the histologic changes reflect the interaction between
the virus on the one hand and the patient on the other, we
here have aimed at a systematic analysis of hepatitis E
histology and its association with clinical parameters.
Materials and methods
Patients and liver tissue samples
Included into this study were 52 liver specimens (48 biop-
sies, 1 liver explant, and 3 autopsy livers) which have been
analyzed at the Department of Pathology and Molecular
Pathology, University Hospital Zurich (USZ) between 2012
and 2018. The cohort comprised cases primarily submitted
to the USZ and cases referred to us from other centers,
including the Cantonal Hospitals St. Gallen and Lucerne,
the University Hospitals Lausanne, Geneva, Basel and
Bern, all Switzerland, the University Hospital Regensburg,
Germany, and the Massachusetts General Hospital, Boston,
MA, USA. For this study, all liver specimens submitted to
our center were included from patients who had molecularly
confirmed HEV infection (n= 41), i.e., having a positive
HEV RNA PCR in blood and/or tissue. Two or more spe-
cimens taken at different time points were analyzed from
eight of the 41 patients. Information on demographic,
clinical, and virological parameters, including age, sex,
immune status, pre-existing LD, and viral genotype, was
retrieved retrospectively from the patient charts. This study
was approved by the internal review board of the USZ and
the Cantonal Ethics Committee of Zurich, Switzerland
(KEK-ZH-Nr. 2013-0504).
Histopathologic evaluation of liver biopsies
All liver specimens were processed according to standard
histologic methods. Stains included hematoxylin & eosin
(H&E) and a connective tissue stain (such as Sirius red or
Masson trichrome stain) for all cases, as well as an addi-
tional periodic acid-Schiff stain after diastase digestion
(PAS-D). Histologic slides were re-evaluated independently
by three experienced liver pathologists (DL, CS, AW). For
all biopsies, the following 33 histopathologic features were
systematically recorded and graded: portal inflammation
(0–3), portal lymphocytes (0–2), portal plasma cells (0–2),
portal histiocytes (0–2), portal ceroid-laden histiocytes
(0–2), portal neutrophils (0–2), portal eosinophils (0–2),
portal edema (no/yes), bile duct damage (0–2), ductular
reaction (no/yes), interface activity (0–3), lobular inflam-
mation (0–3), hepatocyte necrosis (0–3), lobular ceroid-
laden histiocytes (0–2), Kupffer cell activation (0–2), lob-
ular disarray (0–2), rosettes (0–3), anisonucleosis (no/yes),
hepatocyte damage (0–2), Mallory-Denk hyaline (no/yes),
sinusoidal dilatation (no/yes), cholate stasis (no/yes), bilir-
ubinostasis (0–2), steatosis microvesicular (0–2), steatosis
macrovesicular (no/yes), Brunt score for steatosis (0–3)
[20], fibrosis (0–3), sinusoidal fibrosis (no/yes), activity
according to the classifications METAVIR (A0–A3) [21],
and Batts–Ludwig (A0–A4) [22] as well as fibrosis
according to the classifications METAVIR (F0–F4) [21],
Batts–Ludwig (F0–F4) [22], and Ishak (0-6) [23] (Supple-
mentary Table 1).
According to this evaluation, each specimen was assigned
to one of the following five generic histologic patterns
by all three pathologists: (1) Minimal active hepatitis, (2)
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Predominantly lobular hepatitis, (3) Predominantly portal
hepatitis, (4) Steatohepatitis, and (5) Extensive necrosis
(pattern definition see Supplementary Table 2). In case of
discrepancies, consensus was found in a panel discussion.
Statistics
To quantify the inter-rater agreement of the assessments of
the histopathologic features, the weighted kappa statistic
was computed using quadratic weights. For the histologic
pattern variables, the usual kappa statistic was used [24].
Divisive hierarchical clustering of the 33 histopathologic
features was conducted according to the algorithm by
Kaufman and Rousseeuw [25]. Since the histopathologic
features were on ordinal scales with different ranges and a
few values were missing, an extension of Gower’s gen-
eralized dissimilarity coefficient to compute dissimilarities
for the clustering procedures was used (with the algorithm
“daisy” available in the R-package “cluster”) [25]. Gow-
er’s method also allows for different weighting of features.
We assigned a weight of 1 to all features, except the fol-
lowing: Steatosis macrovesicular and Brunt-Score for
steatosis received a weight of 1/2 each, activity METAVIR
and activity Batts–Ludwig received a weight of 1/2 each,
and fibrosis METAVIR, fibrosis Batts–Ludwig, and
fibrosis Ishak received a weight of 1/3 each. This was done
to avoid overweighting these features in the dissimilarity
calculation as they are measures of the same histologic
parameters [25]. Finally, the results of the cluster analysis
were then displayed in a heatmap, in which the histo-
pathologic features have been properly scaled such that
criteria with different number of categories can be com-
pared. All statistical analyses were performed in the R
programming language [26] using base packages, as well
as the psy [27], cluster [28], gplots [29], and vcd [30]
packages.
Results
The cohort comprises mostly HEV genotype 3
infections in immunocompetent as well as
immunocompromised individuals
Basic demographic and clinical characteristics as well as the
results of genotyping were retrospectively retrieved from
the charts of all 41 patients. These are summarized in
Table 1 and listed in more detail in Table 2. From eight
patients, there were two or more liver samples available
over time, yielding a total of 52 liver specimens for ana-
lysis. The age at the first liver biopsy ranged from 10 to 76
years, with a median age of 56 years. Twenty-seven patients
(66%) were male and 14 (34%) were female. HEV infection
was proven molecularly by positive HEV RNA PCR in
blood and/or tissue in all 41 patients. In 32 of these 41
patients, the HEV gt was determined, with the following
distribution: gt 3 in 28 patients (68.3%), gt 1 in three
patients (7.3%), and gt 4 in one patient (2.4%). For nine
patients (22.0%), no information on the HEV genotype was
available.
Four different patient groups were represented based on
clinical considerations [3, 4]. These comprised immuno-
competent individuals without or with known pre-existing
Table 1 Cohort characteristics: patients and liver specimens.
Patients, n 41
Median age at first biopsy (range) 56 (10–76)
Sex male/female, n (%) 27/14 (66%/34%)
HEV genotype (gt), n (%) - gt 1: 3 (7.3%)
- gt 3: 28 (68.3%)
- gt 4: 1 (2.4%)
- NA: 9 (22.0%)
Immune status
- Immunocompetent, n (%) 18/41 (44%)
○ No known pre-existing LD, n (%) - 13/41 (32%)
○ Pre-existing LD, n (%) - 5/41 (12%)
- cirrhosis on ASH ○ 3
- cirrhosis on NASH ○ 1
- cirrhosis on ASH/NASH ○ 1
- Immunocompromised, n (%) 23/41 (56%)
○ TPL (solid organs or HSC), n (%) - 14/41 (34%)
- Liver, n ○ 7
- Kidney, n ○ 2
- Liver and kidney, n ○ 1
- HSC, n ○ 4
○ Otherwise, n (%) - 9/41 (22%)
- RA (methotrexate ± infliximab) ○ 2
- MS (fingolimod) ○ 2
- SLE and cryoglobulinemia (prednisolone
and leflunomide)
○ 1
- AIH (prednisone or prednisolone and
tacrolimus)
○ 2
- CLL (rituximab, leflunomide) ○ 1
- Histiocytosis X (chemotherapy NOS) ○ 1
Liver specimens, n 52
- Biopsy, n (%) - 48/52 (92%)
- Explant liver, n (%) - 1/52 (2%)
- Autopsy liver, n (%) - 3/52 (6%)
AIH autoimmune hepatitis, ASH alcoholic steatohepatitis, CLL chronic
lymphocytic leukemia, gt genotype, HEV hepatitis E virus, HSC
hematopoietic stem cells, LD liver disease, MS multiple sclerosis, NA
not available, NASH nonalcoholic steatohepatitis, NOS not otherwise
specified, RA rheumatoid arthritis, SLE systemic lupus erythematosus,
TPL transplantation.
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LD and immunocompromised patients after transplantation
(solid organ or hematopoietic stem cell (HSC)), or other-
wise immunocompromised. With respect to these cate-
gories, 18 of the 41 patients were immunocompetent
(43.9%), with a total of 21 liver specimens (21/52; 40.4%).
Of these 18 patients, 13 did not have any known pre-
existing LD (13/41; 31.7%), with a total of 13 liver speci-
mens (13/52; 25.0%), and five patients had a known
pre-existing LD (5/41; 12.2%), with a total of eight liver
specimens (8/52; 15.4%). All five patients with known pre-
existing LD had cirrhotic livers. Etiologies of the cirrhosis
included ASH (3/5), NASH (1/5), or ASH/NASH (1/5).
Twenty-tree patients were immunocompromised (23/41;
56.1%), with a total of 31 liver specimens (31/52; 59.6%).
The group of immunocompromised patients comprised 14
patients after solid organ or HSC transplantation (14/41;
34.1%), with totally 22 liver specimens (22/52; 42.3%),
and nine otherwise immunocompromised patients (9/41;
22.0%), with totally nine liver specimens (9/52; 17.3%).
Of the 14 transplanted patients, seven received a liver
(7/14), two a kidney (2/14), one a liver and a kidney
(1/14), and four HSC (4/14). Patients immunocompro-
mised for other reasons included treatment for rheuma-
tologic/autoimmune diseases (i.e., rheumatoid arthritis,
multiple sclerosis, systemic lupus erythematosus, auto-
immune hepatitis) or neoplasia (i.e., chronic lymphocytic
leukemia, histiocytosis X).
A broad and highly variable spectrum of
histopathologic findings can be observed in livers of
patients infected with HEV
First, all 52 liver specimens were re-evaluated indepen-
dently by three expert liver pathologists, each recording
systematically 33 histopathologic features (Supplementary
Table 1). Inter-rater agreement in this independent evalua-
tion was between good to excellent, with kappa values
between 0.4 and 0.9 (two-thirds ≥0.75) for most histo-
pathologic features (Supplementary Fig. 1). The micro-
scopic review revealed a wide range of histopathologic
findings, which varied significantly from case to case. This
spectrum of hepatitis E histology is illustrated in Supple-
mentary Fig. 2a–e. To corroborate the HEV infection on a
tissue level, immunohistochemistry was performed in cases
with sufficient block material, which was possible in a total
of 40 tissue samples. Various staining patterns were
observed as previously described [31]. Remarkably, cases
with only minimal lobular inflammatory activity usually
showed the strongest and most widespread positivity for
HEV ORF2 protein (Supplementary Fig. 2f).
Collectively, these findings demonstrate that on the level
of their histopathologic manifestation, the hepatitis E cases
of the cohort were highly variable.
Hepatitis E presents in five different generic
histologic patterns
Next, we aimed to assign a generic histologic pattern to
each liver specimen. Such patterns are considered to reflect
the limited repertoire of the liver to respond to injuries and
are widely used in routine histopathologic practice to get
direction for the underlying etiology and correct diagnosis
[32]. The cases of our cohort revealed the following dis-
tribution among the five histologic patterns (Fig. 1): (1)
Minimal active hepatitis: 5/52 (9.6%; Fig. 1a), (2) Pre-
dominantly lobular hepatitis: 11/52 (21.2%; Figs. 1b), (3)
Predominantly portal hepatitis: 26/52 (50.0%; Figs. 1c), (4)
Steatohepatitis: 6/52 (11.5%; Fig. 1d) and (5) Extensive
liver necrosis: 4/52 (7.7%; Fig. 1e). Thus, similar as
observed for the individual histopathologic features, also
the histologic patterns displayed a broad distribution
among the cases of our cohort (Table 2 and Supplemen-
tary Fig. 3a). Again, the inter-rater agreement for those
patterns was excellent (kappa value ≥0.75) (Supplemen-
tary Fig. 1). Of note, several of the histologic patterns
were unequally associated with specific patient char-
acteristics, some of them with statistical significance. For
example, in the group of patients with pre-existing LD,
the histologic patterns “steatohepatitis” and “extensive
necrosis” were statistically significantly over-represented,
whereas the pattern of “predominantly portal hepatitis”
was statistically significantly under-represented (Supple-
mentary Fig. 3b).
Collectively, these findings demonstrate that the histo-
pathologic manifestation of hepatitis E covered a broad
spectrum of well-established generic histologic patterns,
some of which were preferentially associated with specific
patient characteristics.
Hierarchical clustering of 33 histopathologic
features identifies three histopathologic clusters of
hepatitis E
With the aim of uncovering any structure that may exist in
this rich data set, regardless of any predetermined cate-
gories such as the patterns previously studied, we then
decided to take a systematic approach by performing a
cluster analysis. The principle of this analysis was to
identify clusters of samples in which the samples within
each cluster were histologically similar, but different from
those in the other clusters. Specifically, we conducted
hierarchical clustering of the samples with respect to the
33 histopathologic features recorded, as well as the other
way around. Remarkably, this approach displayed an easy
to identify structure in the data set, revealing three clusters
of samples (C1–C3) with distinct histopathology. The
liver samples were distributed as follows: Ten of the
D. Lenggenhager et al.
52 samples (19.2%) in C1, 15 samples (28.8%) in C2 and
27 samples (52%) in C3 (Fig. 2). The 33 histopathologic
features were clearly represented differently in the three
clusters. Of note, they were not randomly distributed, but
clustered mainly according to the different pathologies
they reflect (i.e., from top to bottom: features of acute
Fig. 1 Histopathologic findings
observed in hepatitis E
represented in five generic
histologic patterns. a Mimimal
active hepatitis with normal
architecture, minimal portal, and
lobular inflammation and only
single scattered hepatocyte
apoptosis. b Predominantly




hepatocytes, bile duct damage,
signs of beginning removal with
lobular ceroid-laden histiocytes
(PAS stain) and some
parenchymal collapse (Sirius red
stain). c Predominantly portal
inflammation with preserved
lobular architecture and some
interface and lobular
inflammatory activity with few
hepatocyte apoptoses.
Developing fibrosis possible
(Sirius red stain). d Cirrhotic






(Sirius red stain). e Subtotal
necrosis of liver parenchyma
shown here in a cirrhotic liver
(CAB stain). H&E stain, if not
otherwise specified. Scale bars
overviews 400 μm, scale bars
details 50 μm.
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inflammatory activity, features of early subacute inflam-
matory activity, features of late subacute inflammatory
activity, features of chronicity and features of cellular
damage). Only two features (portal edema and sinusoidal
dilatation) did not cluster in any of the above mentioned
groups (Fig. 2).
Each of the three clusters was characterized by a pre-
dominance of different histopathologic features (Fig. 3):
Fig. 2 Hierarchical clustering of histopathologic findings. Hier-
archical clustering of the 52 liver specimens (x axis) with respect to the
33 histopathologic features (y axis) represented in a heatmap: Identi-
fication of three clusters (C1–C3) that segregate along the patient’s
immune status and pre-existing LD. The 33 histopathologic features
clustered mainly according to the different pathologies they reflect
(i.e., from top to bottom: features of acute inflammatory activity,
features of early subacute inflammatory activity, features of late
subacute inflammatory activity, features of chronicity and features of
cellular damage). Only two features (portal edema and sinusoidal
dilatation) did not cluster in any of the above mentioned groups. A
activity, BD bile duct, Ceroid-h. Ceroid-histiocytes, Duct. ductular, F
fibrosis, Hep. hepatocyte, Inflamm. inflammation, Kupffer-c. activ.
Kupffer cell activation, LD liver disease, lob. lobular, MD Mallory-
Denk, port. portal, Sinus. sinusoidal, St. steatosis, TPL transplantation.
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Samples in C1 showed mainly features of acute-on-chronic
LD, such as cirrhosis, necrosis, steatosis, steatohepatitis,
hepatocyte damage, Mallory–Denk hyaline and cholestasis
(Fig. 3a). Samples in C2 displayed mainly features of florid
hepatitis, such as lobular inflammation, parenchymal dis-
array, foci of hepatocyte necrosis and many scattered
apoptotic hepatocytes as well as signs of beginning removal
with lobular ceroid-laden histiocytes, cholestasis and bile
duct damage (Fig. 3b). Samples in C3 were mainly char-
acterized by features of smoldering hepatitis, ranging from
minimal histologic changes over mild to more pronounced
portal based inflammation, mostly with mild interface and
lobular activity with only rare apoptotic hepatocytes, as well
as signs of previous damage such as ceroid-laden histio-
cytes in portal tracts and in some cases with fibrosis
(Fig. 3c).
Thus, similar as observed for the five histologic patterns,
also the three clusters displayed a broad distribution among
the cases of our cohort (Table 2 and Supplementary
Fig. 4a), and were unequally associated with specific patient
characteristics, some of them with statistical significance.
For example, in C1 (acute-on-chronic LD) the group of
patients with pre-existing LD was statistically significantly
over-represented, whereas in C2 (florid hepatitis) the group
of immunocompetent patients without pre-existing LD was
statistically significantly over-represented. In contrast, in C3
Fig. 3 Histopathologic findings
observed in hepatitis E
represented in three
histopathologic clusters. a
Samples in C1 showed mainly
features of acute-on-chronic LD,





bilirubinostasis (from upper left
to lower right). b Samples in C2
displayed mainly features of
florid hepatitis, such as lobular
inflammation and parenchymal
disarray, foci of hepatocyte
necrosis and many scattered
apoptotic hepatocytes as well as
signs of beginning removal with
lobular ceroid-laden histiocytes
(PAS-D stain), cholestasis and
bile duct damage (from upper
left to lower right). c Samples in
C3 were mainly characterized by
features of smoldering hepatitis,
ranging from minimal histologic
changes over predominantly
portal based inflammation with
mild interface and lobular
activity with only rare apoptotic
hepatocytes as well as signs of
previous damage such as ceroid-
laden histiocytes (PAS-D stain)
in portal tracts and in some cases
with fibrosis (Sirius red stain)
(from upper left to lower right).
H&E stain, if not otherwise
specified. Scale bars overviews
400 μm, scale bars details 50
μm. C cluster, LD liver disease.
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Fig. 4 Association of the three clusters with the clinical setting and
the five histologic patterns. Clinico-pathologic settings of the three
clusters including their most relevant differential diagnoses. The
thickness of the lines between the patterns and the clusters represent
the relative association of both. ASH alcoholic steatohepatitis, C
cluster, DILI drug-induced liver injury, GVHD graft-versus-host dis-
ease, LD liver disease, NASH nonalcoholic steatohepatitis, TPL
transplantation.
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(smoldering hepatitis), the group of immunocompetent
patients without pre-existing LD was statistically sig-
nificantly under-represented (Supplementary Fig. 4b).
Collectively, hierarchical clustering with respect to the
33 histopathologic features identified three histopathologic
clusters, which showed distinct histopathologies, some of
which were preferentially associated with specific patient
characteristics.
Three histopathologic clusters reflect different
clinical scenarios
Next, we sought to investigate the association between the
three clusters C1–C3 identified by statistical cluster ana-
lysis methods, and the patients’ immune status and pre-
existing liver condition, considered to be relevant for the
management of patients with hepatitis E [4]. Overall,
it turned out that each of the three clusters C1–C3 was
dominated by one main patient group (Fig. 4): C1 repre-
senting acute-on-chronic liver disease was dominated by
patients with pre-existing LD (8/10; 80%); C2 represent-
ing florid hepatitis was dominated by immunocompetent
patients without known pre-existing LD (9/15; 60%); C3
representing smoldering hepatitis was dominated by
immunocompromised transplanted patients (18/27; 67%).
Samples from patients immunocompromised for other
reasons were found in all three clusters without a clear
predominance. Of note, the five histologic patterns were
represented differently in the three clusters (Fig. 4
and Supplementary Fig. 5a), and the three clusters wer-
e unequally associated with the five patterns, some
of them with statistical significance. For example,
the patterns “extensive necrosis” and “steatohepatitis”
were statistically significantly over-represented in C1
(Supplementary Fig. 5b).
Moreover, we sought to investigate the association
between the three clusters C1–C3 and the outcome with
respect to the HEV infection. After 3 months as well as after
6 months, a strong positive association was found for C1
and “liver failure, death/liver failure, transplantation”, and a
strong negative association was found for C3 “liver failure,
death/liver failure, transplantation.” Furthermore, a strong
positive association was found for C2 and “resolved
infection”, but only after 3 months (Table 2 and Supple-
mentary Fig. 6).
Collectively, these findings not only show that the three
histopathologic clusters are differentially associated with
the five histologic patterns, but also suggest that they
reflect different clinical scenarios, which seem to be
defined by the patients’ immune status and pre-existing
liver condition, and also to affect the outcome of the HEV
infection.
Discussion
The findings of our study provide a rational explanation for
the well-known broad and at first sight puzzling spectrum of
histopathologic changes observed in hepatitis E. These
results were made possible by (1) the availability of a sig-
nificant number of hepatitis E tissue samples from patients
with very different clinical backgrounds and (2) by pursuing
a novel data-driven statistical approach. This allowed us to
also conduct comparative studies on the different clinical
settings of hepatitis E, which goes beyond the previous
reports on narrowly defined cohorts such as hepatitis E in
epidemic outbreaks or in patients with immunosuppression.
With both methods, the traditional pattern-based
approach as well as the cluster analysis, we were able to
structure the broad histopathologic spectrum of hepatitis E
represented in this cohort. Of note, we ultimately found
overlapping results between the two different approaches.
Nevertheless, a strength of the data-driven approach is its
independence of any predetermined category. We therefore
consider the resulting clustering to be a solid basis for the
classification of hepatitis E histopathology.
Of particular interest is the first cluster (C1, acute-on-
chronic liver disease), which includes mainly patients with
pre-existing LD. From a histopathologic perspective, it is
noteworthy that the observed changes were determined
primarily by the respective pre-existing liver disease, i.e.,
cirrhosis on the background of ASH or NASH. Of note,
beside cholestatic changes, considered to reflect hepatic
decompensation, HEV infection in these cases showed no
additional characteristic or even specific histologic features.
As the samples in C1 mostly showed advanced fibrosis or
cirrhosis as well as signs of steatohepatitis, the most
important histopathologic differential diagnosis in this
group is acute (non)alcoholic hepatitis. However, from a
clinical perspective the differential diagnosis is much
broader, including other reasons for acute decompensation
such as bacterial infections, drug-induced liver injury
(DILI), complications of acute bleeding, etc. Five of seven
patients in C1 had cirrhosis and eventually died as a result
of hepatitis E, in line with the previously reported poor
prognosis in this patient group [6, 33]. A detailed clinical
description of the patients with pre-existing LD who died in
the context of HEV infection shall be reported elsewhere.
Interestingly, the two patients in C1 who did not die (pat. 19
and 32), presented with only incomplete cirrhosis, pre-
sumably reflecting a higher reserve in coping with HEV
infection. In conclusion for C1, knowledge and awareness
of the specifics of (acute) hepatitis E in pre-existing liver
disease is essential for both pathologists and clinicians. In
daily practice, pronounced cholestatic changes and/or sig-
nificantly elevated ALT values should prompt them to
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systematically look for reasons for liver decompensation,
including hepatitis E [34].
The second cluster (C2, florid hepatitis) revealed an
overrepresentation of immunocompetent patients without
any known pre-existing LD, but included also five
patients under immunosuppression. The fact that those
five patients presented with high inflammatory activity
may point to a relatively mild immunosuppression at the
time of HEV infection. Histology was dominated by
highly active hepatitis. The three top differential diag-
noses from a pathological as well as from a clinical point
of view are other viral infections, DILI, and autoimmune
hepatitis [17, 35].
The third cluster (C3, smoldering hepatitis) included
mainly patients under (probably more intense) immuno-
suppression. In line with an immune-mediated pathogenesis
of hepatitis E, only mild to moderate inflammatory activity
was observed in these patients. However, 13/22 patients in
this group experienced a prolonged infection (3 months or
longer, i.e., chronic hepatitis E), some of them also with
developing fibrosis, which is in line with the current lit-
erature [7, 16]. In two of the immunocompromised patients
in C3, histology revealed also cirrhotic changes. Patient 22
with chronic lymphocytic leukemia under rituximab/lena-
lidomid treatment had chronic hepatitis E persisting for 4
years. The etiology of liver cirrhosis in this patient was
possibly a combination of hepatitis E and NASH, for which
hints were found in histology. Patient 23 with a history of
rheumatoid arthritis may have developed cirrhosis due
to methotrexate treatment. It is possible that the three
patients classified as immunocompetent in C3 (pat. 10, 16,
and 17) had a hitherto unrecognized immunodeficiency, and
as a consequence developed less active inflammation.
Alternatively, since the biopsies showed clear signs of
subacute inflammation, they may also have been taken at
a later stage of HEV infection. The most important differ-
ential diagnoses from a pathologic as well as from a clinical
point of view are other (viral) infections and DILI, as well
as (acute) T-cell mediated rejection in patients with solid
organ TPL and graft-versus-host disease in patients with
HSC TPL [17, 35, 36].
Interestingly, in one and the same patient, the histologic
changes caused by hepatitis E can vary considerably
depending on the time the biopsy was taken, which most
likely reflects the variable intensity of the patients’ immu-
nosuppression. For example, three biopsies from a liver
transplant patient (pat. 2) clustered in C3 early during
infection, while two biopsies taken at a later point in time
were found in C2.
In routine diagnostics, both the pathologist and the
clinician are not confronted with particular entities but with
their manifestations, from which they must deduce the
distinct etiologies behind them. The findings of our study
suggest that for histopathologic—as well as clinical—
diagnosis of hepatitis E, it is advisable to consider the
patients’ immune status and pre-existing liver condition.
This approach allows to sharpen and narrow down the
differential diagnostic spectrum. For example, when being
confronted with a little active pattern, hepatitis E should be
among the top differential diagnoses in an immunocom-
promised patient, but it may be considered less likely in an
immunocompetent individual.
Considering that the histopathologic changes in a tissue
are a direct reflection of an organism’s exposure to a
harmful agent, such as an infectious particle, it is obvious
that the histopathologic changes observed in relation to a
particular disease are not only of interest to pathology but
also provide insight into the biology of the disease, in
particular with respect to immunologic aspects [37, 38]. We
postulate that the associations of histologic patterns with the
immune status and pre-existing liver condition of patients
shown here reflect not only a random statistical association
but have a causal link.
The cohort underlying this study is, to the best of our
knowledge, the world’s largest hepatitis E biopsy cohort
comprising >50 specimens taken from patients with dif-
ferent immune and liver status, enriched with gt 3 infec-
tions [19]. With a predominance of HEV gt 3 and some
travel associated gt 1 infections, it can be considered
as representative not only for Europe, but also for
North America where awareness of hepatitis E as a rele-
vant health problem has increased recently [4, 39, 40].
Nevertheless, there are some potential limitations. First,
despite the above mentioned high number of hepatitis E
specimens, the sample size is still relatively low with
respect to the applicability of confirmatory statistical
analysis methods. Moreover, our results may not be gen-
eralizable to countries in which other gt predominate, such
as Asia with gt 1 and gt 4 infections. However, it is con-
ceivable that the histopathologic findings of cases of acute-
on-chronic liver failure, as characterized here in C1, could
be caused by gt 1, gt 2 or gt 4 infection as well [41]. Other
potential limitations are the disproportionately high num-
ber of hepatitis E cases with a prolonged/chronic course in
immunocompromised patients, since these are biopsied in
a higher proportion, and the retrospective setting without
standardized conditions, especially for the time point of
the biopsy procurement during the infection.
In summary, the results of our study provide a plausible
explanation for the broad, only at first glance unstructured
histopathologic spectrum observed in hepatitis E, and pro-
vide insight into the underlying determinants. From
these findings we expect not only a better understanding of
the biology of HEV infection, but also guidance to the
pathologic and clinical diagnosis, which should improve the
care of patients with hepatitis E.
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